Systemic lymphoma arising from hydroa vacciniforme-like lymphoma: report of two cases with review of literature

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6403-8. eCollection 2014.


Hydroa vacciniforme-like lymphoma (HVLL) is an extremely rare lymphoma described in children that occurs mainly in Asia and Latin American countries. It is an Epstein-Barr virus (EBV)-positive lymphoproliferative disease (LPD) characterized by a monoclonal proliferation of T or NK cells. In this study, we report the clinical and pathological features of two Chinese patients with HVLL showed T-cell phenotype expressing CD4. The two patients generally presented with similar clinical histories of waxing and waning ulcerative blistering lesions for ten years or more until progression to systemic lymphoma. One patient died two months after progression and another is alive with disease. In the two cases, persistence infection of EBV may be attributed to the disease progression, and systemic lymphoma arising from HVLL behaves in an aggressive fashion and is predisposing to chemotherapeutic agent resistance.

Keywords: Epstein-Barr virus infections; Hydroa vacciniforme; lymphoma.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adolescent
  • Biomarkers, Tumor / analysis
  • Biopsy
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / pathology*
  • CD4-Positive T-Lymphocytes / virology
  • Disease Progression
  • Fatal Outcome
  • Female
  • Herpesvirus 4, Human / genetics
  • Herpesvirus 4, Human / pathogenicity
  • Humans
  • Hydroa Vacciniforme / immunology
  • Hydroa Vacciniforme / pathology*
  • Hydroa Vacciniforme / therapy
  • Hydroa Vacciniforme / virology
  • Immunohistochemistry
  • Lymphoma, T-Cell / immunology
  • Lymphoma, T-Cell / pathology*
  • Lymphoma, T-Cell / therapy
  • Lymphoma, T-Cell / virology
  • Phenotype
  • RNA, Viral / genetics
  • Time Factors
  • Treatment Outcome
  • Young Adult


  • Biomarkers, Tumor
  • RNA, Viral